VolitionRx Limited Gains 46.44%
Tue, Jan 02, 2024 at 07:39 PM
VolitionRx Limited (VNRX:NYSEMKT) jumped higher at $1.05, representing a gain of 46.4%. On Tue, Jan 02, 2024, VNRX:NYSEMKT hit a New 2-Week High of $1.05. The stock appeared on our News Catalysts scanner on Tue, Dec 05, 2023 at 12:17 PM in the 'MISCELLANEOUS' category. From Tue, Dec 19, 2023, the stock recorded 62.50% Up Days and 66.67% Green Days
About VolitionRx Limited (VNRX:NYSEMKT)
VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
Top 10 Gainers:
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 316.25%
- Akso Health Group (AHG:NASDAQ), 61.2%
- Dogness (International) Corporation (DOGZ:NASDAQ), 54.73%
- Polished Inc Com (POL:NYSEMKT), 52.24%
- VolitionRx Limited (VNRX:NYSEMKT), 46.44%
- NGM Biopharmaceuticals, Inc. (NGM:NASDAQ), 45.52%
- PolyPid Ltd. (PYPD:NASDAQ), 43.42%
- Kelso Technologies Inc. (KIQ:NYSEMKT), 42.17%
- Peak Bio Inc Com (PKBO:NASDAQ), 41.15%
- Cue Health Inc. (HLTH:NASDAQ), 40.43%